Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

50 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients

NCT02523638

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • LKH Graz Graz, Austria
  • University Hospital Innsbruck Innsbruck, Austria
  • Elisabethinen Hospital Linz Linz, Austria
  • Salzburg Regional Hospital Salzburg, Austria
View all 35 locations
View Trial Details
Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • Novartis Investigative Site Cardiff, Wales, United Kingdom
  • Novartis Investigative Site Bournemouth, United Kingdom
  • Novartis Investigative Site East Yorkshire, United Kingdom
  • Novartis Investigative Site Edinburgh, United Kingdom
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Ahmedabad, Gujarat, India
  • Local Institution - 0001 New Delhi, National Capital Territory of Delhi, India
  • Local Institution - 0007 Kolkata, West Bengal, India
  • Local Institution - 0005 Assam, India
View Trial Details

Related conditions